Ismail D Legason, MSc, BSc, MPH^1,2,3*, Adam Burns, PhD^3*, Kate Ridout, PhD^3*, Daisy Jennings, MSc^3*, Martin D Ogwang, MBChB, MMed(Surgery)^1*, Isaac Otim, MSc^1*, Hadijah Nabalende, BSc^1*, Caroline Achola, MBChB, MMed(Path)^4*, Alisen Ayitewala, MSc^4*, Julius Sseruyange, BSc^4*, Clara C Chamba, MD, MMed^5*, Emmanuel Josephat, MSc^5*, Heavenlight Christopher, MSc^5*, William F Mawalla, MD^5*, Elifurah Mkwizu, MD, MMed^6,7*, Alex Mremi, PhD^6,7*, Hadija Mwamtemi, MD, MMed^8*, Helene Dreau, MSc^3*, Claire El Mouden, DPhil^3*, Dimitris Vavoulis, PhD^3*, Carol Sze Leung, PhD^9* and Anna Schuh, MD, PhD, FRCP, FRCPath³

¹St. Mary's Hospital Lacor, Gulu, Uganda
²Faculty of Health Sciences, Muni University, Arua, Uganda
³Department of Oncology, University of Oxford, Oxford, United Kingdom
⁴Central Public Health Laboratories, Kampala, Uganda
⁵Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania, United Republic of
⁶Kilimanjaro Christian Medical Centre, Moshi, Tanzania, United Republic of
⁷Kilimanjaro Christian Medical University College, Moshi, Tanzania, United Republic of
⁸Department of Paediatrics, Muhimbili National Hospital, Dar-es-Salaam, Tanzania, United Republic of
⁹Ludwig Institute for Cancer Research, University of Oxford, Oxford, United Kingdom

Jaewoo Choi, PhD¹, Michele Ceribelli, PhD^2*, James D Phelan, PhD^1*, Björn Häupl, PhD^3*, Da Wei Huang^1*, George Wright^4*, Tony Hsiao^5*, Vivian M Morris^6*, Francesco Ciccarese, PhD^7*, Boya Wang, BSc⁸, Sean R Corcoran, PhD^5*, Sebastian Scheich, MD^9*, Xin Yu^1*, Weihong Xu^8*, Yandan Yang^1*, Joyce Zhou^5*, Grace Zhang^5*, Jagan R. Muppidi, MD, PhD^1*, Giorgio Inghirami, MD^10*, Thomas Oellerich, Prof. MD^11*, Craig J. Thomas, PhD^2* and Louis M. Staudt, MD, PhD¹²

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Division of Pre-Clinical Innovation Chemistry Technologies, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD
³Goethe University, Frankfurt Am Main, Germany
⁴Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵NIH/NCI, Bethesda
⁶Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda
⁷Veneto Institute of Oncology, Padova, ITA
⁸NIH/NCI, Bethesda, MD
⁹Goethe University, Frankfurt Am Main, DEU
¹⁰Weill Cornell Medicine, New York, NY
¹¹Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany
¹²NIH-National Cancer Institute, Bethesda, MD

Anna Katharina Foerster, MD^1*, Corinna Kronenthaler^2*, Lavanya Ranganathan^2*, Samuel Bandara^3*, Corinna Woestmann^4*, Stephanie Yaung, PhD^3*, Sabine Bleul^2*, Christian Klingler, PhD^2*, Jan Mitschke, PhD^5*, Julius Wehrle, MD^2*, Ralph Wäsch, MD⁶, Justus Duyster, MD^6*, Tim Struessmann, MD^2*, Jürgen Finke, MD⁶, Bowdoin Su, MD^7*, Reinhard Marks, MD^6* and Florian Scherer, MD^6,8

¹Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg Im Breisgau, Baden-Württemberg, Germany
²Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
³Roche Diagnostics Solutions, Santa Clara, CA
⁴Signature Diagnostics GmbH, Potsdam, Germany
⁵Department of Internal Medicine I, Medical university Center Freiburg, Freiburg im Breisgau, Germany
⁶Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
⁷Roche Molecular Systems, Santa Clara, CA
⁸German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany

Kennedee Weber^1*, Aidan Forberg^1*, Jordan Unrau, BS^1*, Alison Rutz^1*, Shelby Lund, BS^1*, Jackson Hauge^1*, Ainslee Hemmen^1* and Keenan T Hartert, PhD²

¹Minnesota State University, Mankato
²Minnesota State University, Mankato, MN

Marta Lafuente^1*, Ramon Diez-Feijoo^1,2*, Concepción Fernández-Rodríguez^1,3*, Raquel Longarón^1,3*, Lierni Fernández-Ibarrondo^1*, Nieves Garcia-Gisbert^1,3*, Marta García-Recio^4*, Blanca Sanchez-Gonzalez^1,2*, Sergio Pinzon^1,2*, Joan Gibert^1*, Laura Camacho^1,3*, Luis Colomo^3*, Antonio Gutierrez^4*, Beatriz Bellosillo^1,3* and Antonio Salar^1*

¹Hospital del Mar Medical Research Institute, Barcelona, Spain
²Hematology Department, Hospital del Mar, Barcelona, Spain
³Pathology Department, Hospital del Mar, Barcelona, Spain
⁴Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain

Nicholas J. Boddicker, PhD¹, Raphael Mwangi, M.S.^2*, Dennis P. Robinson, PhD^3*, Cristine Allmer, BS^4*, Allison C. Rosenthal, DO⁵, Thomas M. Habermann, MD⁶, Andrew L. Feldman, MD⁷, Lisa M. Rimsza, MD⁸, Rebecca King, MD^4*, Melissa C. Larson, MS^9*, Brianna Gysbers^4*, Aaron D. Norman^9*, Stephen M Ansell, MD, PhD⁶, Angela Dispenzieri, MD⁴, David L Murray, MD, PhD^10*, S. Vincent Rajkumar, MD⁴, Shaji Kunnathu Kumar, MD⁶, Jithma Prasad Abeykoon, MD¹¹, Grzegorz S. Nowakowski, MD⁶, Thomas E. Witzig, MD⁴, Anne J. Novak, PhD⁴, Celine M. Vachon, PhD⁹, Susan L. Slager, PhD⁶ and James R. Cerhan, MD, PhD¹²

¹Division of Computational Biology, Mayo Clinic, Rochester, MN
²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN
⁵Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
⁸Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
⁹Division of Epidemiology, Mayo Clinic, Rochester, MN
¹⁰Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
¹¹Mayo Clinic, Boston, MN
¹²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Lindsey Armitage, BA^1*, Sarah Gibson, MD², Pedro S de Carvalho, BS MS^3*, Lee Wisner, AA^1*, Joo Y Song, MD^4*, Wing C. Chan, MD⁴, Jennifer R. Chapman-Fredricks, MD^5*, Francisco Vega, MD, PhD⁶, Stefano A. Pileri, MD, PhD⁷, Louis de Jager, MD^8*, Fabio E Leal, MD^3*, Lisa M. Rimsza, MD⁹ and Alanna Maguire, PhD¹⁰

¹Research, Mayo Clinic Scottsdale, Scottsdale, AZ
²Mayo Clinic Arizona, Phoenix, AZ
³Programa de Oncovirologia, Instituto Nacional de Cancer Jose de Alencar, Rio de Janeiro, Brazil
⁴Department of Pathology, City of Hope National Medical Center, Duarte, CA
⁵Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL
⁶Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
⁷Division of Hematopathology, Istituto Europeo di Oncologia, Milano, Italy
⁸Division of Anatomical Pathology, Stellenbosch University, Cape Town, South Africa
⁹Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
¹⁰Mayo Clinic Arizona, Scottsdale, AZ

Manuela Cruz, B.Sc^1*, Kostiantyn Dreval^2,3*, Prasath Pararajalingam, BSc^3*, Laura Hilton, PhD^2*, Jasper Wong^4*, Christopher Rushton, PhD^5* and Ryan Morin, PhD^2,5

¹Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, BC, CAN
²Genome Sciences Center, BC Cancer Research Institute, Vancouver, BC, Canada
³Simon Fraser University, Burnaby, BC, CAN
⁴University of British Columbia, Vancouver, BC, CAN
⁵Simon Fraser University, Burnaby, BC, Canada

Alyssa Bouska, PhD^1*, Weiwei Zhang, Ph.D^2*, Sunandini Sharma, MS^2*, Harald Holte, MD, PhD³, Ab Rauf Shah, Ph.D^2*, Waseem Gul Lone, PhD^2*, Luca Vincenzo Cappelli, MD, PhD^4*, Danilo Fiore, Ph.D^5,6*, Qiang Gong, PhD^7*, Tayla Heavican-Foral, PhD², Jeffrey Cannatella, M.D.^2*, Catalina Amador, MD^8*, Aiza Arif^2*, Lynette Smith, Ph.D^9*, Soon Thye Lim, MBBS, MRCP^10*, Choon Kiat Ong, Ph.D^11*, Andrew L. Feldman, MD¹², Ming-Qing Du, MB, PhD, FRCPath¹³, Laurence de Leval, MD, PhD¹⁴, Timothy C. Greiner, MS, MD^2*, Kai Fu, MD, PhD¹⁵, Gunhild Trøen, PhD^16*, Daniel Vodak^17*, Sigve Nakken, PhD^18*, Jan Delabie, MD, PhD^19*, David M. Weinstock, MD²⁰, Stefano A. Pileri, MD, PhD²¹, Antonella Laginestra, Ph.D^22*, Kyeongjin Kim, PhD^23*, Utpal Pajvani, MD, PhD^24*, Julie M. Vose, MD, MBA²⁵, Dennis D Weisenburger, MD^2*, Sandeep Dave, M.D.^26*, Giorgio Inghirami, MD^27*, Wing C. Chan, MD⁷ and Javeed Iqbal, PhD, MSc^2*

¹Department of Pathology and Microbiology, University of Nebraska Medical Center, OMAHA, NE
²Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
³Department of Oncology, Oslo University Hospital, Oslo, NOR
⁴Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
⁵1. Department of Pathology and Laboratory Medicine, Weil Cornell Medical College, New York City, NY
⁶Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
⁷Department of Pathology, City of Hope National Medical Center, Duarte, CA
⁸University of Miami, Miami, FL
⁹Department of Biostatistics, UNMC, Omaha, NE
¹⁰National Cancer Centre, Singapore, Singapore, SGP
¹¹Division of Medical Oncology, National Cancer Centre Singapore / Duke-NUS Medical School, Singapore, Singapore, Singapore
¹²Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
¹³Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
¹⁴Hôpital Universitaire de Lausanne, Lausanne, Switzerland
¹⁵Department of Pathology & Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁶Oslo University Hospital, Oslo, Norway
¹⁷Oslo University Hospital,, Oslo, Norway
¹⁸University of Oslo, Oslo, Norway
¹⁹University of Toronto, Toronto, ON, CAN
²⁰Dana Farber Cancer Institute, Boston, MA
²¹Division of Hematopathology, Istituto Europeo di Oncologia, Milano, Italy
²²European Institute of Oncology IRCCS,, Milan, Italy
²³Inha University, Incheon, KOR
²⁴Columbia University, New York, NY
²⁵University of Nebraska Medical Center, Omaha, NE
²⁶Duke University Medical Center, Durham, NC
²⁷Weill Cornell Medicine, New York, NY

Xinyu Zhu, M.D.^1*, Bing Xiu^2*, Jingjing Zhu, master^3*, Zhi-Zhang Yang, MD⁴ and Aibin Liang, MD^5*

¹Hematology, Tongji Hospital of Tongji University, Shanghai, Shanghai, China
²Tongji hospital of tongji university, Shanghai, China
³General medicine, Central hospital of Putuo Distinct, Shanghai, China
⁴Hematology, Mayo Clinic, Rochester, MN
⁵Tongti Hospital of Tongji University, Shanghai, Shanghai, China

Ethan C. Whipp, MSc^1*, Janek S. Walker, PhD^2*, Mehdi Gharghabi, PharmD^2*, Casey Cempre^2*, Brandi Walker, BS^2* and Rosa Lapalombella, PhD²

¹Comprehensive Cancer Center - Wexner Medical Center, The Ohio State University, Columbus, OH
²The Ohio State University, Columbus, OH

Ryan N Rys^1*, Elie Ritch, PhD^2*, Christopher Rushton, PhD^2*, Abdelrahman Ahmed^3*, Eugene Brailovski, MD^4*, Christian Steidl, MD, PhD⁵, David W. Scott, MBChB, PhD⁶, Ryan D Morin, PhD⁷ and Nathalie A. Johnson, MD, PhD,⁴

¹McGill University, Montreal, QC, CAN
²Simon Fraser University, Burnaby, BC, Canada
³Lady Davis Institute, Montreal, QC, Canada
⁴McGill University, Montreal, QC, Canada
⁵Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁶Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
⁷Simon Fraser University, Burnaby, BC, CAN

Wu Yin, PhD¹, Min Ye^2*, Netonia Marshall^1*, Joanne BL Tan¹, Evan Paull^1*, Zhe Nie^1*, MIchael Trzoss^1*, Goran Krilov^1*, Shulu Feng^1*, Robert Pelletier^1*, Jeff Bell^1*, Peter Skrdla^1*, David Calkins^1*, MaryBeth Grimes^1*, D. Hamish Wright¹ and Karen Akinsanya^1*

¹Schrödinger, Inc., New York, NY
²Schröinger, Inc., New York, NY

Hiroki Kobayashi, MD^1*, Ryota Chijimatsu, PhD^2*, Ryo Mizuta, MD^3*, Kentaro Fujii, MD, PhD^3*, Yoshihiro Otani, MD, PhD^3*, Joji Ishida, MD, PhD^3*, Yusuke Naoi, MD^2,4*, Hiroyuki Murakami, MD^5*, Hideki Ujiie^6*, Kazuhiro Ikeuchi, MD^5*, Tomohiro Urata, MD^5*, Katsuma Tani, MD^5*, Akira Yamamoto, MD, PhD^7*, Keisuke Seike, MD, PhD^7*, Hideaki Fujiwara, MD, PhD⁷, Noboru Asada, MD, PhD⁷, Hisakazu Nishimori, MD, PhD^7*, Keiko Fujii, MD, PhD^8*, Nobuharu Fujii, MD, PhD^9*, Ken-ichi Matsuoka, MD, PhD^7*, Yasuharu Sato, PhD^10*, Tadashi Yoshino, MD, PhD^11*, Yoshinobu Maeda, MD, PhD⁵ and Daisuke Ennishi, MD, PhD¹²

¹Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kamogawa, CHI, Japan
²Center of Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan
³Department of Neurological surgery, Okayama University, Okayama, Japan
⁴Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, OKA, Japan
⁵Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
⁶Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan
⁷Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
⁸Division of Clinical Laboratory, Okayama University Hospital, Okayama, Japan
⁹Division of Blood Transfusion, Okayama University Hospital, Okayama, Japan
¹⁰Department of Molecular Hematopathology, Okayama University, Okayama, Japan
¹¹Department of Pathology, Okayama University, Okayama, Japan
¹²Okayama University Hospital, Okayama, Japan

Habib Hamidi, MPH, PhD^1*, Patrick Kimes, PhD^1*, Aaron Schroeder, BS^1*, Jasmina Uzunovic, MSc^2*, Adam J Olszewski, MD³, Jason Sit, PharmD, PhD^1*, Enkhtsetseg Purev, MD, PhD^1*, Donald Yee, MD^1* and Ron McCord, PhD^1*

¹Genentech, Inc., South San Francisco, CA
²Hoffmann-La Roche Ltd, Mississauga, ON, Canada
³Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI

Franck Morschhauser, MD PhD¹, Wilfred Leung, PhD^2*, Vibha Raghavan, MSc^3*, Georg Lenz⁴, Fabrice Jardin, MD PhD^5*, Alex F. Herrera, MD⁶, Laurie H. Sehn, MD, MPH⁷, Jeff P. Sharman, MD⁸, Christopher R. Flowers, MD, MS⁹, Jonathan W. Friedberg, MD, MMSc¹⁰, Marek Trněný, MD¹¹, Hervé Tilly, MD, PhD⁵, Charles Herbaux, MD, PhD^12*, Samuel Tracy, PhD^2*, Christopher R. Bolen, PhD^2*, Will Harris, MS^2*, Jamie H. Hirata, PharmD^13*, Calvin Lee, MD², Yanwen Jiang, PhD^2* and Gilles Salles, MD, PhD¹⁴

¹University of Lille, Lille, France
²Genentech, Inc., South San Francisco, CA
³Hoffmann-La Roche Ltd, Mississauga, ON, Canada
⁴University of Münster, Munster, Germany
⁵Centre Henri-Becquerel and University of Rouen, Rouen, France
⁶City of Hope, Duarte, CA
⁷BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁸Willamette Valley Cancer Institute and Research Center, Eugene, OR
⁹Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
¹⁰University of Rochester, Rochester, NY
¹¹Charles University General Hospital, Prague, Czech Republic
¹²Institute of Human Genetics, CNRS UM UMR 9002, University of Montpellier, MONTPELLIER, France
¹³Genentech, South San Francisco, CA
¹⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Preetesh Jain, MD, MBBS, PhD, DM¹, Holly A Hill, MS^2*, Chi Young Ok, MD³, Alexander Nesmalov, PhD^4*, Vitaly Segodin^5*, Dmitry Tabakov, PhD^6*, Nikita Kotlov^6*, Pavel Zemskiy^7*, Eleonora Belykh^8*, Krystle Nomie, PhD^6*, Ahmed Fetooh, MD^9*, Rashmi Kanagal-Shamanna, MD¹⁰, Fatima Z Jelloul^11*, Guilin Tang, MD, PhD^3*, Francisco Vega, MD, PhD¹², Nathan Fowler, MD^6*, Christopher R. Flowers, MD, MS¹³ and Michael L. Wang, MD¹⁴

¹Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴BostonGene Corporation, Waltham, MA
⁵BostonGene Coroporation, Boston
⁶BostonGene, Corp., Waltham, MA
⁷boston gene, MA, MA
⁸Boston Gene corp, MA
⁹Lymphoma/ Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Hematopathology, MD Anderson Cancer Center, Houston, TX
¹¹Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
¹³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Lymphoma/ Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Elise Sourdeau^1*, Martin Chevalier^2*, Hélène Masse^3*, Julie Gueudry^4*, Yann Maucourant^5*, Marie-Laure Le Lez^6*, Philippe Gohier^7*, Marie Alice Laville^8*, Nathalie Cassoux, MD, PhD^9*, Fatma Abid Mzid^10*, Mohamed Ali Gargouri^11*, Marie Marechal^12*, Guido Ahle^13*, Clotilde Devin^14*, Sara Touhami^2*, Valerie Touitou^15*, Caroline Houillier^16*, Khe Hoang-Xuan, MD, PhD^17*, Choquet Sylvain^18*, Carole Soussain, MD¹⁹, Adélaïde Toutee^2* and Magali Le Garff-Tavernier^14*

¹Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Pitie-Salpetriere Hospital, Paris, France, FRA
²Ophtalmology Department, Assistance Publique-Hôpitaux de Paris, Pitie-Salpetriere Hospital, Paris, France
³Ophtalmology Department, Centre Hospitalo-Universitaire de Nantes, Nantes, France
⁴Ophtalmology Department, Centre Hospitalo-Universitaire de Rouen, Rouen, France
⁵Ophtalmology Department, Centre Hospitalo-Universitaire de Rennes, Rennes, France
⁶Ophtalmology Department, Centre Hospitalier Régional Universitaire de Tours, Tours, France
⁷Ophtalmology Department, Centre Hospitalo-Universitaire d'Angers, Angers, France
⁸Ophtalmology Department, Centre Hospitalo-Universitaire de Caen, Caen, France
⁹Ophtalmology Department, Institut Curie, Université de Paris Cité, Paris, FRA
¹⁰Ophtalmology Department, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France
¹¹Ophtalmology Department, Fondation ophtalmologique Adolphe de Rothschild, Paris, France
¹²Ophtalmology Department, Hôpital d’Instruction des Armées Percy, Clamart, France
¹³Neurology Department, Hôpitaux Civils de Colmar, Colmar, France
¹⁴Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Pitie-Salpetriere Hospital, Paris, France
¹⁵AP-HP, HôPital Pitié-salpêtrièRe, Paris, FRA
¹⁶Neuro-Oncology Department, Assistance Publique des Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, FRA
¹⁷Neuro Oncology Department, Assistance Publique-Hôpitaux de Paris, Pitie-Salpetriere Hospital, Paris, FRA
¹⁸Hopital de la Pitié Salpetrière, APHP, Paris, FRA
¹⁹Hôpital René Huguenin - Institut Curie, Saint-Cloud, FRA

Sofia Huerga^1*, Beñat Ariceta^2*, Paula Aguirre-Ruiz^3*, Patxi San-Martin^2*, Sarai Sarvide^2*, Marta Abengozar-Muela, MD^4*, Diego Alignani^2*, Rocio Figueroa, MD, PhD^1*, Carlos Grande, MD, PhD^1*, Alvaro Lopez-Janeiro, MD^5*, Emma Muiños-Lopez, PhD^3*, Juan Roberto Rodriguez-Madoz, PhD^2*, Amaia Vilas-Zornoza^2*, Felipe Prosper, MD, PhD¹ and Miguel Canales^6*

¹Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN) and Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Pamplona, Spain
²Hematology and Oncology Program, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
³Hematology and Oncology Program, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain, Pamplona, Spain
⁴Department of Pathology, Clinica Universidad de Navarra (CUN), Pamplona, Spain
⁵Departament of Pathology, Clínica Universidad de Navarra, Pamplona, Spain
⁶Clinica Universidad de Navarra Cancer Center (CCUN), Pamplona, Spain

Dmitry Kazantsev, PhD^1*, Magdalena Klanova^2,3*, Michal Kolář, PhD^4*, Robert Ivánek, PhD^5*, Marek Trněný, MD⁶ and Pavel Klener Jr.^7,8*

¹First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Prague, Czech Republic
²First Dept. of Internal Medicine- Hematology, General University Hospital, Charles University, Prague 2, AL, Czech Republic
³Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
⁴Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, CZE
⁵Department of Biomedicine, University of Basel, Basel, Switzerland
⁶First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
⁷First Dept. of Internal Medicine- Hematology, University General Hospital in Prague and First Faculty of Medicine, Charles University, Praha 2, Czech Republic
⁸First Faculty of Medicine, Charles University, Praha 2, Czech Republic

Christopher R. Bolen, PhD^*, Sumedha Roy^*, Ling-Yuh Huw, PhD^*, Katerina Hatzi, PhD^* and Elicia Penuel, PhD

Genentech, Inc., South San Francisco, CA

Manik Uppal, MD^1*, Erel Joffe, MD^2*, Kurt S. Bantilan, MPH^1*, Gilles Salles, MD, PhD³, Jacob Soumerai, MD⁴, Andrew D. Zelenetz, MD, PhD¹ and Anita Kumar, MD⁵

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Tel Aviv Medical Center, Tel Aviv, Israel
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁴Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ